HARVARD BIOSCIENCE, INC. (HBIO) Return on equity 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-412.8%FY2025 · since FY2016: -6.0% → -412.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -412.8% | -393.3 pp |
| FY2024 | -19.6% | -14.9 pp |
| FY2023 | -4.7% | +8.5 pp |
| FY2022 | -13.2% | -12.8 pp |
| FY2021 | -0.3% | +9.8 pp |
| FY2020 | -10.2% | -4.4 pp |
| FY2019 | -5.7% | -2.2 pp |
| FY2018 | -3.5% | -2.5 pp |
| FY2017 | -1.1% | +4.9 pp |
| FY2016 | -6.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice